Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Liberatore, Gabriel T., Jackson-Lewis, Vernice, Vukosavic, Slobodanka, Mandir, Allen S., Vila, Miquel, McAuliffe, W. Geoffrey, Dawson, Valina L., Dawson, Ted M. +1 more·1999·Nature Medicine
DOI 10.1038/70978

Cited by (1,000)

Items 301–400 of 1,000

  1. The Toll-Like Receptor-3 Agonist Polyinosinic:Polycytidylic Acid Triggers Nigrostriatal Dopaminergic Degeneration
    Michela Deleidi, Penelope J. Hallett, James B. Koprich, Chee Yeun Chung, Ole Isacson A · 2010 · Journal of Neuroscience
  2. NO-cGMP Signaling and Regenerative Medicine Involving Stem Cells
    K. S. Madhusoodanan, Ferid Murad · 2006 · Neurochemical Research
  3. Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson’s disease
    Bin Liu · 2006 · The AAPS Journal
  4. The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration
    Jared T. Hinkle, Valina Lynn Dawson, Ted M. Dawson · 2019 · Movement Disorders
  5. Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice
    Randy L. Hunter, Baohua Cheng, Dong‐Young Choi, Mei Liu, Shuwei Liu, Wayne A. Cass, Guoying Bing · 2009 · Journal of Neuroscience Research
  6. Neuronal pathology in Parkinson?s disease
    Jörg Bernhard Schulz · 2005 · Cell and Tissue Research · Retracted
  7. Reactive Macrophages Increase Oxidative Stress and Alpha-Synuclein Nitration During Death of Dopaminergic Neuronal Cells in Co-Culture: Relevance to Parkinson’s Disease
    Shavali Shaik, Colin Kelly Combs, Manuchair Ebadi · 2006 · Neurochemical Research
  8. Differential Reactions of Microglia to Brain Metastasis of Lung Cancer
    Bei Ping He, Jian Jun Wang, Xian Zhang, Yan Wu, Miao Wang, Boon‐Huat Bay, Alex Yuang-Chi Chang · 2006 · Molecular Medicine
  9. Liver X receptor β protects dopaminergic neurons in a mouse model of Parkinson disease
    Yu-bing Dai, Xin-jie Tan, Wan-fu Wu, Margaret N. Warner, Jan-Ακε Gustafsson · 2012 · Proceedings of the National Academy of Sciences
  10. Protective Effects of Salidroside in the MPTP/MPP+-Induced Model of Parkinson's Disease through ROS–NO-Related Mitochondrion Pathway
    Songhai Wang, Hong He, Lei Chen, Wei Zhang, Xiaojun Zhang, Jianzong Chen · 2014 · Molecular Neurobiology
  11. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity
    Ji‐Young Choi, Eun-Hee Jang, Chang‐Shin Park, Ju‐Hee Kang · 2005 · Free Radical Biology and Medicine
  12. Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice
    Estelle Rousselet, Chantal Joubert, Jacques Callebert, Karine Parain, Léon Tremblay, Gaël Orieux, Jean‐Marie Launay, Charles Cohen‐Salmon, Étienne C. Hirsch · 2003 · Neurobiology of Disease
  13. Inflammation and Parkinson's disease pathogenesis
    Serge Przedborski · 2010 · Movement Disorders
  14. Role of Fcγ Receptors in Nigral Cell Injury Induced by Parkinson Disease Immunoglobulin Injection into Mouse Substantia Nigra
    Yi He, Weidong Le, Stanley H. Appel · 2002 · Experimental Neurology
  15. Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease
    Mika Shimoji, Li Zhang, Allen S. Mandir, Valina Lynn Dawson, Ted M. Dawson · 2005 · Molecular Brain Research
  16. Altered dopamine signaling and MPTP resistance in mice lacking the Parkinson's disease-associated GPR37/parkin-associated endothelin-like receptor
    Daniela Marazziti, Elisabetta Golini, Silvia Mandillo, Armando Magrelli, Walter Witke, Rafaele Matteoni, Glauco P. Tocchini‐Valentini · 2004 · Proceedings of the National Academy of Sciences
  17. Bee Venom Reduces Neuroinflammation in the MPTP-Induced Model of Parkinson's Disease
    Jong‐In Kim, Eun Jin Yang, Myeong Soo Lee, Yong Suk Kim, Youngbuhm Huh, Ik‐Hyun Cho, Sung-Keel Kang, Hyung-Kyun Koh · 2011 · International Journal of Neuroscience
  18. Iron Oxide Nanoparticles Induce Dopaminergic Damage: In vitro Pathways and In Vivo Imaging Reveals Mechanism of Neuronal Damage
    Syed Z. Imam, Susan M. Burks, Elvis Cuevas, Héctor Rosas-Hernández, Serguei M. Liachenko, Yongbin Zhang, Sumit Sarkar, Jaivijay Ramu, Bonnie L. Robinson, Yvonne Jones et al. · 2015 · Molecular Neurobiology
  19. Suppression of Inflammation with Conditional Deletion of the Prostaglandin E <sub>2</sub> EP2 Receptor in Macrophages and Brain Microglia
    Johansson, Jenny U., Pradhan, Suraj, Lokteva, Ludmila A., Woodling, Nathaniel S., Ko, Novie, Brown, Holden D., Wang, Qian, Loh, Christina, Cekanaviciute, Egle, Buckwalter, Marion et al. · 2013 · The Journal of Neuroscience
  20. Drug Insight: effects mediated by peroxisome proliferator-activated receptor-γ in CNS disorders
    Michael Thomas Heneka, Gary E. Landreth, Michael Hüll · 2007 · Nature Clinical Practice Neurology
  21. Interferon-γ plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways
    Emily N. Mangano, Darcy Litteljohn, Remmick So, Eric Nelson, Sarah Peters, Cheri Bethune, Jessica Bobyn, Shawn P. Hayley · 2011 · Neurobiology of Aging
  22. Upregulation of CCAAT/enhancer binding protein β in activated astrocytes and microglia
    Aroa Ejarque‐Ortiz, Manel G. Medina, Josep M. Tusell, Anna Pérez-González, Joan Serratosa, Josep Saura · 2006 · Glia
  23. Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease
    Broom, Lauren, Marinova-Mutafchieva, Lilia, Sadeghian, Mona, Davis, John B., Medhurst, Andrew D., Dexter, David T. · 2011 · Free Radical Biology and Medicine
  24. Mitochondrial DNA and inflammatory diseases
    Germaine Escames, Luis Carlos López, José Antonio García, Laura García‐Corzo, Francisco Ortiz, Darı́o Acuña-Castroviejo · 2011 · Human Genetics
  25. S-nitrosylation regulates mitochondrial quality control via activation of parkin
    Kentaro Ozawa, Akira T. Komatsubara, Yuhei Nishimura, Tomoyo Sawada, Hiroto Kawafune, Hiroki Tsumoto, Yuichi Tsuji, Jing Zhao, Yoji Kyotani, Toshio Tanaka et al. · 2013 · Scientific Reports
  26. Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK
    Duy-Khanh Dang, Eun‐Joo Shin, Yunsung Nam, Sungwoo Ryoo, Ji Hoon Jeong, Choon‐Gon Jang, Toshitaka Nabeshima, Jau‐Shyong Hong, Hyoung‐Chun Kim · 2016 · Journal of Neuroinflammation
  27. Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson’s disease model
    Yunlong Zhang, Xiaoliang He, Xingjun Meng, Xiaojuan Wu, Huichun Tong, Xiuping Zhang, Shaogang Qu · 2017 · Cell Death and Disease
  28. Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease
    Briana R. De Miranda, Emily M. Rocha, Qing Bai, Amina El Ayadi, David Hinkle, Edward A. Burton, J. Timothy Greenamyre · 2018 · Neurobiology of Disease
  29. TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons
    Maatouk, Layal, Compagnion, Anne-Claire, Sauvage, Maria-Angeles Carrillo-de, Bemelmans, Alexis-Pierre, Leclere-Turbant, Sabrina, Cirotteau, Vincent, Tohme, Mira, Beke, Allen, Trichet, Michaël, Bazin, Virginie et al. · 2018 · Nature Communications
  30. Neuroprotective Properties of Green Tea (Camellia sinensis) in Parkinson’s Disease: A Review
    Dicson Sheeja Malar, Mani Iyer Prasanth, James Michael Brimson, Rajasekharan Sharika, Bhagavathi Sundaram Sivamaruthi, Chaiyavat Chaiyasut, Tewin Tencomnao · 2020 · Molecules
  31. Induction of CHOP and apoptosis by nitric oxide in p53‐deficient microglial cells
    Kohichi Kawahara, Seiichi Oyadomari, Tomomi Gotoh, Shinichi Kohsaka, Hitoshi Nakayama, Masataka Mori · 2001 · FEBS Letters
  32. Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease
    Vı́ctor Tapias, Jason R. Cannon, J. Timothy Greenamyre · 2013 · Neurobiology of Aging
  33. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons
    Xin Guo, Valina Lynn Dawson, Ted M. Dawson · 2001 · European Journal of Neuroscience
  34. New Animal Models for Parkinson's Disease
    Ted M. Dawson · 2000 · Cell
  35. Pro-inflammatory gene expression and neurotoxic effects of activated microglia are attenuated by absence of CCAAT/enhancer binding protein β
    Marco Straccia, Núria Gresa‐Arribas, Guido Dentesano, Aroa Ejarque‐Ortiz, Josep M. Tusell, Joan Serratosa, Carme Solà, Josep Saura · 2011 · Journal of Neuroinflammation
  36. Nitric Oxide
    Kochupurackal P. Mohanakumar, Bobby Thomas, Sudarshana M. Sharma, Dhanasekharan Muralikrishnan, Rukhsana Chowdhury, Chuang C. Chiueh · 2002 · Annals of the New York Academy of Sciences
  37. A Potent Inhibitor of Inducible Nitric Oxide Synthase, ONO-1714, a Cyclic Amidine Derivative
    Masao Naka, Toshiyuki Nanbu, Kaoru Kobayashi, Yoshihisa Kamanaka, Masaharu Komeno, Ryo Yanase, Tatsushi Fukutomi, Shinsei Fujimura, Han Geuk Seo, Noriko Fujiwara et al. · 2000 · Biochemical and Biophysical Research Communications
  38. A lincRNA-p21/miR-181 family feedback loop regulates microglial activation during systemic LPS- and MPTP- induced neuroinflammation
    Yongyi Ye, Xiaozheng He, Fengfei Lu, Hengxu Mao, Zhiyuan Zhu, Longping Yao, Wanxian Luo, Xiang Sun, Baoyan Wang, Chen Qian et al. · 2018 · Cell Death and Disease
  39. Role of extracellular signal‐regulated protein kinase in neuronal cell death induced by glutathione depletion in neuron/glia mesencephalic cultures
    Sonsoles de Bernardo, Santiago Canals, Marı́a José Casarejos, Rosa Maria Solano, J. Menendez, M. A. Mena · 2004 · Journal of Neurochemistry
  40. Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor α or 1-methyl-4-phenylpyridinium treatment
    Carine Fillebeen, Marie‐Magdeleine Ruchoux, Valerie A. Mitchell, Sylvie Vincent, Monique Benaı̈ssa, Annick Pierce · 2001 · Molecular Brain Research
  41. Animal models of Parkinson’s disease in rodents induced by toxins: an update
    Étienne C. Hirsch, Günter U. Höglinger, Estelle Rousselet, Tilo Breidert, Karine Parain, Jean Féger, Merle Ruberg, Annick Prigent, Charles Cohen‐Salmon, Jean‐Marie Launay · 2003 · Journal of neural transmission. Supplementum
  42. A novel in vivo post‐translational modification of p53 by PARP‐1 in MPTP‐induced parkinsonism
    Allen S. Mandir, Cynthia Marie Simbulan-Rosenthal, Marc F. Poitras, John R. Lumpkin, Valina Lynn Dawson, Mark E. Smulson, Ted M. Dawson · 2002 · Journal of Neurochemistry
  43. Toxin-Induced and Genetic Animal Models of Parkinson's Disease
    Shin Hisahara, Shun Shimohama · 2010 · Parkinson s Disease
  44. Modeling neuroinflammatory pathogenesis of Parkinson’s disease
    Christopher J. Barnum, Malú G. Tansey · 2010 · Progress in brain research
  45. CD4+ T cells mediate cytotoxicity in neurodegenerative diseases
    Stanley H. Appel · 2008 · Journal of Clinical Investigation
  46. Fractalkine: moving from chemotaxis to neuroprotection
    Diane Bérangère Ré, Serge Przedborski · 2006 · Nature Neuroscience
  47. Microglial cells and Parkinson’s disease
    Qian Li, Patrick M. Flood · 2008 · Immunologic Research
  48. Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation
    Wei Bi, Lihong Zhu, Chuanming Wang, Yanran Liang, Jun Liu, Qiaoyun Shi, Enxiang Tao · 2011 · Brain Research
  49. Involvement of Nitric Oxide in Maneb- and Paraquat-Induced Parkinson’s Disease Phenotype in Mouse: Is There Any Link with Lipid Peroxidation?
    Satya P. Gupta, Suman Patel, Sharawan Yadav, Anand Kumar Singh, Seema K. Singh, Mahendra Pratap Singh · 2010 · Neurochemical Research
  50. Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system
    Hernández-Romero, Mª Carmen, Delgado-Cortés, Mª José, Sarmiento, Manuel, de Pablos, Rocío M., Espinosa-Oliva, Ana María, Argüelles, Sandro, Bández, Manuel J., Villarán, Ruth F., Mauriño, Raquel, Santiago, Marti et al. · 2012 · NeuroToxicology
  51. dl-3-n-Butylphthalide prevents oxidative damage and reduces mitochondrial dysfunction in an MPP+-induced cellular model of Parkinson's disease
    Jinzhong Huang, Ying-zhu Chen, Min Su, Hui-fen Zheng, Yaping Yang, Jing Chen, Chun-Feng Liu · 2010 · Neuroscience Letters
  52. Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson’s Disease
    Nicoletta Schintu, Lucia Frau, Marcello Ibba, Arianna Garau, Ezio Carboni, Anna Rosa Carta · 2009 · Neurotoxicity Research
  53. Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.
    S. Dhib-Jalbut, D. Arnold, D. W. Cleveland, M. Fisher, Robert M. Friedlander, M. Mouradian, S. Przedborski, Bruce D. Trapp, T. Wyss-Coray, Wee V. Yong · 2006 · Journal of Neuroimmunology
  54. Possible Involvement of Complement Factor C1q in the Clearance of Extracellular Neuromelanin From the Substantia Nigra in Parkinson Disease
    Candan Depboylu, Martin K.-H. Schafer, Óscar Arias-Carrión, Wolfgang Hermann Oertel, Eberhard Weihe, Günter U. Höglinger · 2011 · Journal of Neuropathology & Experimental Neurology
  55. Increased vulnerability of dopaminergic neurons in MPTP‐lesioned interleukin‐6 deficient mice
    L. Bolin, Iwona Strycharska-Orczyk, R. Murray, J. Langston, D. D. Di Monte · 2002 · Journal of Neurochemistry
  56. TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration
    Giacomo Tondo, Daniela Perani, Cristoforo Comi · 2019 · Disease Markers
  57. Oxidation and nitration of α-synuclein and their implications in neurodegenerative diseases
    Cecilia Chavarría, José M. Souza · 2013 · Archives of Biochemistry and Biophysics
  58. Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease
    Erzsebet Kokovay, Lee Anna Cunningham · 2005 · Neurobiology of Disease
  59. Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity
    Dan Zhang, Xiaoming Hu, Qian Li, Shih‐Heng Chen, Hui Zhou, Belinda C. Wilson, David S Miller, Jau‐Shyong Hong · 2011 · Journal of Neuroinflammation
  60. Inhibition of inducible nitric oxide synthase expression and cell death by (−)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
    Ji‐Seon Kim, Jong-Min Kim, O Jeong-Ja, Beom S. Jeon · 2010 · Journal of Clinical Neuroscience
  61. Neuroprotective Effect of Curcuminoids Against Inflammation-Mediated Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease
    Rudra Prakash Ojha, Manisha Rastogi, B. Parimala Devi, Aruna Agrawal, Govind Prasad Dubey · 2012 · Journal of Neuroimmune Pharmacology
  62. Metallothionein Attenuates 3-Morpholinosydnonimine (SIN-1)-Induced Oxidative Stress in Dopaminergic Neurons
    Sushil K. Sharma, Manuchair Ebadi · 2003 · Antioxidants and Redox Signaling
  63. Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders
    Mark Frederick McCarty · 2006 · Medical Hypotheses
  64. Nitric oxide in neurodegeneration: potential benefits of non-steroidal anti-inflammatories
    Gayle Helane Doherty · 2011 · Neuroscience Bulletin
  65. Recent Advances in the Study of Bipolar/Rod-Shaped Microglia and their Roles in Neurodegeneration
    Ngan Pan Bennett Au, Chi Him Eddie Ma · 2017 · Frontiers in Aging Neuroscience
  66. A Novel Role for Sema3A in Neuroprotection from Injury Mediated by Activated Microglia
    Henry Majed, Siddharthan Chandran, Simone P. Niclou, Richard S. Nicholas, Alastair Wilkins, Mark G Wing, Kate E. Rhodes, Maria Grazia Spillantini, Alastair Compston · 2006 · Journal of Neuroscience
  67. JAK2-STAT3 signaling pathway mediates thrombin-induced proinflammatory actions of microglia in vitro
    Chengfang Huang, Rong Ma, Shenggang Sun, Guirong Wei, Yuan Fang, Rengang Liu, Gang Li · 2008 · Journal of Neuroimmunology
  68. Inhibition of Interferon (IFN) γ-induced Jak-STAT1 Activation in Microglia by Vasoactive Intestinal Peptide
    Mario Delgado · 2003 · Journal of Biological Chemistry
  69. Nitric Oxide Signaling in Neurodegeneration and Cell Death
    Ted M. Dawson, Valina Lynn Dawson · 2017 · Advances in pharmacology
  70. Neuronal pathology in Parkinson?s disease
    Jörg Bernhard Schulz, Björn H. Falkenburger · 2004 · Cell and Tissue Research · Retracted
  71. Nitric Oxide in the Nervous System
    Marcelo Cossenza, Renato Socodato, Camila Cabral Portugal, Ivan Domith, Luis Gladulich, Thaísa Godinho da Encarnação, Karin da Costa Calaza, Henrique Rocha Mendonça, Paula Campello‐Costa, Roberto Paes‐de‐Carvalho · 2014 · Vitamins and hormones
  72. The chemokine stromal cell‐derived factor‐1/CXCL12 activates the nigrostriatal dopamine system
    Delphine Skrzydelski, Alice Guyon, Valérie Daugé, Carole Rovère, Emmanuelle Apartis, Patrick Kitabgi, Jean‐Louis Nahon, William H. Rostène, Stéphane Melik Parsadaniantz · 2007 · Journal of Neurochemistry
  73. Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson’s disease
    Hironori Yokoyama, Hayato Kuroiwa, Ryohei Yano, Tsutomu Araki · 2008 · Neurological Sciences
  74. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication
    Wanida Tripanichkul, Kittisak Sripanichkulchai, David Isaac Finkelstein · 2006 · Brain Research
  75. IL-13-induced oxidative stress via microglial NADPH oxidase contributes to death of hippocampal neurons in vivo
    Park, Keun W, Baik, Hyung H, Jin, Byung K · 2009 · The Journal of Immunology
  76. Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress
    Eun S. Chung, Young Cheul Chung, Eugene Bok, Hyung Hwan Baik, Eun Su Park, Ju‐Young Park, Sung‐Hwa Yoon, Byung Kwan Jin · 2010 · Brain Research
  77. Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid
    Sangho Choi, Francesca Bosetti · 2009 · Aging
  78. Oxidative Modifications of α‐Synuclein
    Harry Ischiropoulos · 2003 · Annals of the New York Academy of Sciences
  79. Immunomodulation of Parkinson’s disease using Mucuna pruriens (Mp)
    Sachchida Nand, Hareram Birla, Walia Zahra, Saumitra Sen Singh, Surya Pratap Singh · 2017 · Journal of Chemical Neuroanatomy
  80. Pathologic Modifications of α-Synuclein in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Treated Squirrel Monkeys
    Alison L. McCormack, Sally K. Mak, Maryam Shenasa, J. William Langston, Lysia S. Forno, Donato A. Di Monte · 2008 · Journal of Neuropathology & Experimental Neurology
  81. Nitric oxide and sleep
    Sabine M. Gautier, Damien Colas, Pierre Parmantier, Pierre Clément, Abdallah Gharib, Nicole Sarda, Raymond Cespuglio · 2005 · Sleep Medicine Reviews
  82. Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration
    Tomohiro Nakamura, Chang-ki Oh, Xu Zhang, Stuart A. Lipton · 2021 · Free Radical Biology and Medicine
  83. Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
    Ross B. Mounsey, Peter Teismann · 2010 · Parkinson s Disease
  84. Activation of nuclear transcription factor kappa B (NF‐κB) is essential for dopamine‐induced apoptosis in PC12 cells
    Hana Panet, Ari Barzilai, Dvora Daily, Eldad Melamed, Daniel Offen · 2001 · Journal of Neurochemistry
  85. MAPKAP kinase 2‐deficiency prevents neurons from cell death by reducing neuroinflammation – relevance in a mouse model of Parkinson’s disease
    Tobias A. Thomas, Marco Timmer, Konstantin Cesnulevicius, Edward Hitti, Alexey Kotlyarov, Matthias Gaestel · 2008 · Journal of Neurochemistry
  86. Neuroprotective effect of asiatic acid on rotenone-induced mitochondrial dysfunction and oxidative stress-mediated apoptosis in differentiated SH-SYS5Y cells
    Jagatheesan Nataraj, Thamilarasan Manivasagam, Arokiasamy Justin Thenmozhi, Musthafa Mohamed Essa · 2016 · Nutritional Neuroscience
  87. Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system
    Afrah Abdul Ismaiel, Ana M. Espinosa‐Oliva, Martiniano Santiago, Albert García-Quintanilla, Maria José Oliva-Martín, Antonio J. Herrera, Jose Luis Venero, Rocío M. de Pablos · 2016 · Toxicology and Applied Pharmacology
  88. Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson’s disease
    Ren‐Hong Du, Hongbin Sun, Zhaoli Hu, Ming Lu, Jianhua Ding, Gang Hu · 2018 · Cell Death and Disease
  89. Overexpression of Parkin Ameliorates Dopaminergic Neurodegeneration Induced by 1- Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice
    Minjuan Bian, Jie Liu, Xiaoqi Hong, Mei Yu, Yu‐Fang Huang, Zhejin Sheng, Jian Fei, Fang Ping Huang · 2012 · PLoS ONE
  90. Neuro-protective effects of bee venom by suppression of neuroinflammatory responses in a mouse model of Parkinson’s disease: Role of regulatory T cells
    Eun Sook Chung, Himchan Kim, Gihyun Lee, Soojin Park, Hyunseong Kim, Hyunsu Bae · 2012 · Brain Behavior and Immunity
  91. Nitric Oxide, Iron and Neurodegeneration
    Chao Liu, Mui Cheng Liang, Tuck Wah Soong · 2019 · Frontiers in Neuroscience
  92. The effect of α‐synuclein knockdown on MPP+ toxicity in models of human neurons
    Timothy M. Fountaine, Lara Lourenço Venda, Nicholas Warrick, Helen Christian, Patrik Brundin, Keith M. Channon, Richard Wade‐Martins · 2008 · European Journal of Neuroscience
  93. Ethyl Pyruvate Rescues Nigrostriatal Dopaminergic Neurons by Regulating Glial Activation in a Mouse Model of Parkinson’s Disease
    Sue Hee Huh, Young Cheul Chung, Ying Piao, Min Y Jin, Hyo Jin Son, Nam Soo Yoon, Joo Y. Hong, Youngmi Kim Pak, Yoon S. Kim, Jong Ki Hong et al. · 2011 · The Journal of Immunology
  94. Resveratrol in Rodent Models of Parkinson’s Disease: A Systematic Review of Experimental Studies
    Cheng-Fu Su, Jiang Li, Xiaowen Zhang, Ashok Iyaswamy, Min Li · 2021 · Frontiers in Pharmacology
  95. Neuroprotective and Anti-inflammatory Properties of a Coffee Component in the MPTP Model of Parkinson's Disease
    Kang‐Woo Lee, Joo‐Young Im, Jongmin Jacob Woo, Hilary Grosso Jasutkar, Yoon‐Seong Kim, Ana Clara Cristóvão, Patricia K. Sonsalla, David S. Schuster, Marla M. Jalbut, José Ramón Fernández et al. · 2013 · Neurotherapeutics
  96. The role of α-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response
    Mikhail Y. Golovko, Gwendolyn Barceló‐Coblijn, Paula I. Castagnet, Susan A. Austin, Colin Kelly Combs, Eric J. Murphy · 2008 · Molecular and Cellular Biochemistry
  97. Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease
    R. Kurosaki, Yasuko Muramatsu, Hiroyuki Kato, Tsutomu Araki · 2004 · Pharmacology Biochemistry and Behavior
  98. Compartmentalized oxidative stress in dopaminergic cell death induced by pesticides and complex I inhibitors: Distinct roles of superoxide anion and superoxide dismutases
    Humberto Rodríguez‐Rocha, Aracely García‐García, C.Suzanne Pickett, Sumin Li, Jocelyn Jones, Han Chen, Brian Webb, Jae Hyuk Choi, You Zhou, Matthew Christopher Zimmerman et al. · 2013 · Free Radical Biology and Medicine
  99. Parthanatos in the pathogenesis of nervous system diseases
    Xuanzhong Wang, Pengfei Ge · 2020 · Neuroscience
  100. MPTP and SNpc DA neuronal vulnerability: Role of dopamine, superoxide and nitric oxide in neurotoxicity. Minireview.
    Vernice R. Jackson-Lewis, Richard Jay Smeyne · 2005 · Neurotoxicity Research